Market Overview

Stifel Nicolaus Initiates Coverage on AVEO Pharmaceuticals at Sell

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for AVEO

DateFirmActionFromTo
Dec 2013RBC CapitalDowngradesSector PerformUnderperform
May 2013Canaccord GenuityDowngradesBuyHold
May 2013Stifel NicolausUpgradesSellHold

View More Analyst Ratings for AVEO
View the Latest Analyst Ratings

Posted-In: Price Target Initiation Analyst Ratings

 

Related Articles (AVEO)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→